These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12678752)

  • 1. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues.
    Desbène S; Giorgi-Renault S
    Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):71-90. PubMed ID: 12678752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.
    Sackett DL
    Pharmacol Ther; 1993 Aug; 59(2):163-228. PubMed ID: 8278462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series.
    Etievant C; Schambel P; Guminski Y; Barret JM; Imbert T; Hill BT
    Anticancer Drug Des; 1998 Jun; 13(4):317-36. PubMed ID: 9627671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morpholino derivatives of benzyl-benzodioxole, a study of structural requirements for drug interactions at the colchicine/podophyllotoxin binding site of tubulin.
    Batra JK; Jurd L; Hamel E
    Biochem Pharmacol; 1986 Nov; 35(22):4013-8. PubMed ID: 3778522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
    Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
    Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and Biochemical Characterization of the Interaction of Tubulin with Potent Natural Analogues of Podophyllotoxin.
    Antúnez-Mojica M; Rodríguez-Salarichs J; Redondo-Horcajo M; León A; Barasoain I; Canales Á; Cañada FJ; Jiménez-Barbero J; Alvarez L; Díaz JF
    J Nat Prod; 2016 Aug; 79(8):2113-21. PubMed ID: 27518758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor agents. I. DNA topoisomerase II inhibitory activity and the structural relationship of podophyllotoxin derivatives as antitumor agents.
    Terada T; Fujimoto K; Nomura M; Yamashita J; Kobunai T; Takeda S; Wierzba K; Yamada Y; Yamaguchi H
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2720-7. PubMed ID: 1334447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor.
    Hernández ÁP; Díez P; García PA; Pérez-Andrés M; Ortega P; Jambrina PG; Díez D; Castro MÁ; Fuentes M
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32957517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemi-synthesis and biological activity of new analogues of podophyllotoxin.
    Roulland E; Magiatis P; Arimondo P; Bertounesque E; Monneret C
    Bioorg Med Chem; 2002 Nov; 10(11):3463-71. PubMed ID: 12213460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
    ter Haar E; Rosenkranz HS; Hamel E; Day BW
    Bioorg Med Chem; 1996 Oct; 4(10):1659-71. PubMed ID: 8931935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
    Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs.
    Kelleher JK
    Cancer Treat Rep; 1978 Oct; 62(10):1443-7. PubMed ID: 101303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of 4'-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design.
    Niu L; Wang Y; Wang C; Wang Y; Jiang X; Ma L; Wu C; Yu Y; Chen Q
    Biochem Biophys Res Commun; 2017 Nov; 493(1):718-722. PubMed ID: 28864414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors.
    Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N
    Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent
    Lu Y; Wang L; Wang X; Yuan H; Zhao Y
    Future Med Chem; 2019 Dec; 11(23):3015-3027. PubMed ID: 31668097
    [No Abstract]   [Full Text] [Related]  

  • 16. Antileishmanial activity and tubulin polymerization inhibition of podophyllotoxin derivatives on Leishmania infantum.
    Escudero-Martínez JM; Pérez-Pertejo Y; Reguera RM; Castro MÁ; Rojo MV; Santiago C; Abad A; García PA; López-Pérez JL; San Feliciano A; Balaña-Fouce R
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):272-285. PubMed ID: 28719882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization.
    Ma Y; Fang S; Li H; Han C; Lu Y; Zhao Y; Liu Y; Zhao C
    Chem Biol Drug Des; 2013 Jul; 82(1):12-21. PubMed ID: 23786349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discover 4β-NH-(6-aminoindole)-4-desoxy-podophyllotoxin with nanomolar-potency antitumor activity by improving the tubulin binding affinity on the basis of a potential binding site nearby colchicine domain.
    Zhao W; He L; Xiang TL; Tang YJ
    Eur J Med Chem; 2019 May; 170():73-86. PubMed ID: 30878833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure--antitubulin activity relationship in steganacin congeners and analogues. Inhibition of tubulin polymerization in vitro by (+/-)-isodeoxypodophyllotoxin.
    Zavala F; Guenard D; Robin JP; Brown E
    J Med Chem; 1980 May; 23(5):546-9. PubMed ID: 7381854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
    Wang RW; Rebhum LI; Kupchan SM
    Cancer Res; 1977 Sep; 37(9):3071-9. PubMed ID: 560248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.